Spring til hovednavigation Spring til søgning Spring til hovedindhold

Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy

Ole Jannik Bjerrum, Sascha Eichendorff, Nada Bassam Alkis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

OriginalsprogEngelsk
TidsskriftTherapeutic Innovation & Regulatory Science
Antal sider6
ISSN2168-4790
DOI
StatusUdgivet - 2019

Citationsformater